Alcon AG vs Globalstar — how do they compare? Alcon AG trades at $66.03 (market cap $32.08B), while Globalstar trades at $82.48 (market cap $10.69B). The key difference: Alcon AG is far larger — about 3× Globalstar's market cap, and Alcon AG pays a 0.54% dividend while Globalstar pays none. Which is the better fit depends on your goals.
| ALC | GSAT | |
|---|---|---|
Market Cap | $32.08B | $10.69B |
Sector | Health | Technology |
52-Week High | $87.18 | $84.43 |
52-Week Low | $62.02 | $29.94 |
Enterprise Value | $35.92B | $10.69B |
Dividend Yield | 0.54% | — |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.03, down 0.78% today, with a bearish technical signal from moving averages but bullish oscillators. Revenue grew to $10.40B in 2025, though net income dipped to $980M. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 profit outlook. Analyst consensus is bullish with a $85.85 price target, supported by new product launches and tariff relief.
Outlook is positive due to strong analyst support and operational execution, but risks include intense competition and margin pressure. The stock offers potential upside to the price target, though investors should monitor earnings consistency and macroeconomic headwinds.
GSAT trades at $82.48, up 0.62% today, with a neutral technical signal and bullish moving averages. The company reported a Q2 2026 net loss of $0.23 per share, missing estimates, while revenue reached $273 million in 2025. Recent news highlights the successful launch of eight replacement satellites, bolstering its communications constellation.
The outlook remains cautious due to persistent losses and high valuation multiples, but satellite deployment progress offers growth potential. Key risks include execution challenges and competitive pressures in the satellite communications sector.
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →